Journal
APL BIOENGINEERING
Volume 7, Issue 3, Pages -Publisher
AIP Publishing
DOI: 10.1063/5.0155037
Keywords
-
Categories
Ask authors/readers for more resources
In recent years, there has been an increasing demand for highly predictive brain cancer models to test new anticancer compounds and experimental therapeutic approaches. Realistic in vitro brain tumor-on-a-chip platforms can lead to more accurate selection of potential drugs, reducing the economic and ethical issues associated with unsuccessful in vivo studies.
In recent years, the need for highly predictive brain cancer models to test new anticancer compounds and experimental therapeutic approaches has significantly increased. Realistic in vitro brain tumor-on-a-chip platforms would allow a more accurate selection of valid candidate drugs and nanomedicines, therefore alleviating the economic and ethical issues of unsuccessful studies in vivo. Here, we present a multi-functional self-assembled brain tumor-on-a-chip model characterized by 3D glioma cultures interfaced both to nonmalignant brain cells of the peritumoral niche and to a 3D-real-scale blood-brain barrier (BBB) microfluidic system. This platform allowed us to screen multiple features, such as BBB crossing capabilities, apoptotic efficacy against GBM cells, and side effects on nonmalignant brain cells of a promising anticancer drug, nutlin-3a, which is fundamental for the treatment of brain cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available